Atlas Trials

Study of Clinical Efficacy and Safety of Tosedostat in MDS

Clinical trial NCT02452346 · COMPLETED

Trial details

NCT number
NCT02452346
Sponsor
Weill Medical College of Cornell University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndrome
Start date
2015-03-20
Primary completion
2017-10-25
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.